Hitachi to provide CNAO with proton therapy system
The Japanese company Hitachi has entered into an agreement to provide Centro Nazionale di Adroterapia Oncologica (CNAO) with its proton therapy system.
CNAO, a beneficiary member of the OMA network located in Pavia (Italy), is a world's leading clinical center on particle cancer therapy and the first national hadrontherapy center in Italy. CNAO has been delivering cancer treatment with proton therapy since 2011 and heavy ion therapy since 2012. The centre is currently developing a new proton therapy facility to enhance further research and cancer treatment.
In comprehensive public tender process, Hitachi has been selected to provide a proton therapy system with the latest technologies, including advanced scanning to irradiate tumours with complex shapes with high precision. This will be the 1st Hitachi Proton Therapy System to be installed in Italy and the 2nd in Europe.
Hitachi has been proactively promoting particle therapy systems, supplying world-class facilities with highly reliable machines, which have treated more than 60,000 patients worldwide.